Document Detail

Pharmacogenetics of oral anticoagulants.
MedLine Citation:
PMID:  16093729     Owner:  NLM     Status:  MEDLINE    
The use of oral anticoagulants (OA) is problematic due to its association with hemorrhagic complications. OA metabolism relies on the CYP2C9 complex. Genetic variations compromising metabolic competence of this complex may explain the risk of excessive and hazardous anticoagulation. A pharmacogenetics-based approach to this issue could be beneficial for choosing adequate dose and duration of treatment, in addition to having a better understanding of pharmacological interactions to which OA are susceptible. However, evidence from several basic and clinical studies indicates that both a complicated system of regulation of expression of multiple genes and the influence of a wide variety of epigenetic factors could be responsible for adverse drug reactions associated with the use of OA. Emphasis on understanding the gene-environment interactions could attain new paths to facilitate the use of these important drugs in the quotidian clinical practice.
Julio César Rojas; Bernardo Aguilar; Emma Rodríguez-Maldonado; María Teresa Collados
Related Documents :
17201079 - Delayed thrombin generation is not associated with fibrinopeptide formation during prol...
82839 - Alpha2-plasmin-inhibitor deficiency (miyasato disease).
5295579 - Hemorrhage during long-term anticoagulant drug therapy. ii. gastrointestinal hemorrhage.
15954549 - Acute hemoperitoneum in horses: a review of 19 cases (1992-2003).
12523469 - Warfarin and acetaminophen interaction.
15567459 - An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis...
6144229 - Neuroleptic neurotoxicity; electro-clinical aspects.
15898829 - Herbal interactions involving cytochrome p450 enzymes: a mini review.
10634199 - A comparison of exposure groups in the eurosida study: starting highly active antiretro...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis     Volume:  16     ISSN:  0957-5235     ISO Abbreviation:  Blood Coagul. Fibrinolysis     Publication Date:  2005 Sep 
Date Detail:
Created Date:  2005-08-11     Completed Date:  2006-03-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9102551     Medline TA:  Blood Coagul Fibrinolysis     Country:  England    
Other Details:
Languages:  eng     Pagination:  389-98     Citation Subset:  IM    
Center for Research and Extension in Health Sciences, Instituto Tecnológico y de Estudios Superiores de Monterrey, Nuevo Leon, Mexico.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Oral
Anticoagulants / administration & dosage,  adverse effects,  pharmacokinetics*
Aryl Hydrocarbon Hydroxylases / genetics*
Biotransformation / genetics
Epigenesis, Genetic*
Gene Expression Regulation / drug effects
Reg. No./Substance:
0/Anticoagulants; EC Hydrocarbon Hydroxylases; EC protein, human

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Inheritance of total serum IgE in the isolated Tangier Island population from Virginia: complexities...
Next Document:  Generation of tissue factor-rich microparticles in an ex vivo whole blood model.